Advertisement

Topics

Peloton Therapeutics, Inc. Company Profile

11:35 EDT 18th September 2018 | BioPortfolio

Peloton Therapeutics is a drug discovery and development company focused on advancing first-in-class small molecule therapies for cancer and other life-threatening diseases. Initial efforts are focused on hypoxia inducible factor-2α (HIF-2α), which has been implicated in the development and progression of several types of cancers. Peloton’s lead candidate, PT2385, is the first HIF-2α inhibitor to enter clinical development and is being evaluated in a Phase 1 clinical trial for the treatment of advanced or metastatic clear cell renal cell carcinoma (ccRCC). Peloton is headquartered in Dallas, TX and was founded in 2011 by Professor Steven McKnight and The Column Group. The company raised more than $30 million in a Series C financing in October 2014 to fund its development activities for PT2385 as well as advance its research pipeline. Peloton is backed by The Column Group, Remeditex Ventures, Tichenor Ventures, Topspin Fund, Nextech Invest, and other investors. For more information, please visit www.pelotontherapeutics.com.


News Articles [720 Associated News Articles listed on BioPortfolio]

Peloton doses first patient in Phase ll trial of PT2977

Peloton Therapeutics has dosed the first patient in a Phase ll trial investigating the efficacy and safety of PT2977 for...Read More... The post Peloton doses first patient in Phase ll trial of PT2977...

Peloton Therapeutics Appoints Alan A. Musso Chief Financial Officer

Peloton Therapeutics, Inc., today announced the appointment of Alan A. Musso as Chief Financial Officer (CFO), effective September 4, 2018. Mr. Musso brings significant financial ...

Peloton Therapeutics, Inc. to Present Phase 1 Data Evaluating its Oral HIF-2α Inhibitor PT2977 ...

Data demonstrate favorable safety, pharmacokinetics, and pharmacodynamics profile of PT2977 with early evidence of clinical activity Read more...

Peloton Therapeutics, Inc. Appoints Helen S. Kim, M.B.A. and David Chang, M.D., Ph.D. to Board of Directors

Peloton Therapeutics, Inc., announced today the appointment of two new members to the company’s Board of Directors. The new members are Helen S. Kim, former Executive Vice Presi...

Peloton Therapeutics Initiates Phase 2 Trial of Oral HIF-2α Inhibitor PT2977 for Treatment of von Hippel-Lindau Disease-associated Kidney Cancer

Peloton Therapeutics, Inc., announced today dosing of the first patient in a Phase 2 trial evaluating the efficacy and safety of lead investigational oncology agent, PT2977, to tr...

Peloton Therapeutics, Inc. to Present Phase 1 Data Evaluating its Oral HIF-2α Inhibitor PT2977 in Patients with Advanced Solid Tumors at 2018 ASCO Annual Meeting

Data demonstrate favorable safety, pharmacokinetics, and pharmacodynamics profile of PT2977 with early evidence of clinical activity Peloton Therapeutics, Inc., announc...

Peloton Acquires Neurotic Media LLC to Enhance Its Members’ Music Experience

Fitness Technology Brand Enhances Music Offerings with Addition of Atlanta-based Music Technology Platform, Marking the Company’s First-Ever Acquisition Pel...

Peloton Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 10052018] Prices from USD $250

SummaryPeloton Therapeutics Inc Peloton is a clinicalstage pharmaceutical company that develops oral medicines and novel therapies for oncology. Its portfolio of pipeline products includes PT2977, PT2...

PubMed Articles [431 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Eyes on New Product Development: Preclinical Research.

Clinical Trials [153 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1255 Associated Companies listed on BioPortfolio]

Peloton Therapeutics, Inc.

Peloton Therapeutics is a drug discovery and development company focused on advancing first-in-class small molecule therapies for cancer and other life-threatening diseases. Initi...

The Peloton

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Peloton Therapeutics, Inc." on BioPortfolio

We have published hundreds of Peloton Therapeutics, Inc. news stories on BioPortfolio along with dozens of Peloton Therapeutics, Inc. Clinical Trials and PubMed Articles about Peloton Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Peloton Therapeutics, Inc. Companies in our database. You can also find out about relevant Peloton Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record